The synthesis of a diaminopurine PNA monomer, N-[N 6 -(benzyloxycarbonyl)-2,6-diaminopurine-9-yl] acetyl-N-(2-t-butyloxycarbonylaminoethyl)glycine, and the incorporation of this monomer into PNA oligomers are described. Substitution of adenine by diaminopurine in PNA oligomers increased the T m of duplexes formed with complementary DNA, RNA or PNA by 2.5-6.5_C per diaminopurine. Furthermore, discrimination against mismatches facing the diaminopurine in the hybridizing oligomer is improved. Finally, a homopurine decamer PNA containing six diaminopurines is shown to form a (gel shift) stable strand displacement complex with a target in a 246 bp double-stranded DNA fragment.
INTRODUCTION
Peptide nucleic acid (PNA) is a nucleic acid mimic in which the entire phosphodiester backbone has been replaced by a pseudopeptide (polyamide). This backbone consists of repeating units of aminoethylglycine with the nucleobases attached through a methylene carbonyl linker. It has been shown that PNA oligomers form highly stable complexes with complementary oligonucleotides (1) (2) (3) (4) . Mixed purine/pyrimidine oligomers of PNA form 1:1 complexes with Watson-Crick complementary DNA, RNA or PNA oligomers (4), whereas homopyrimidine PNA oligomers bind in a 2:1 (PNA:nucleic acid) mode (1) (2) (3) 5) . PNA has attracted broad attention in the fields of medicinal and bioorganic chemistry as well as in molecular biology and the chemistry and biological and physical properties of PNA were recently reviewed (6-9).
2,6-Diaminopurine (D) is a naturally occurring nucleobase found in, for example, the cyanophage S-2L, where it extensively replaces adenine (10) . Since a diaminopurine-thymine base pair resembles a guanine-cytosine base pair ( Fig. 1 ) in terms of both number of hydrogen bonds (three) and extent of interbase pair stacking overlap, duplex stabilization by D-T base pairs is expected. It has been shown that incorporation of diaminopurine into short DNA oligomers increases the thermal stability of the duplex by 0-2_C per D-T base pair (11) . It has also been shown that the sequence specificity was improved in some cases (12) . Thus a similar increased affinity and specificity upon incorporation of diaminopurine could be expected for PNA-nucleic acid complexes.
We report the synthesis of a diaminopurine monomer (N-[N 6 -(benzyloxycarbonyl)-2, 6-diaminopurine-9-yl] acetyl-N-(2-t-butyloxycarbonylaminoethyl)glycine) and its incorporation into PNA oligomers. In addition, we show that incorporation of a D-T base pair into a PNA-NA heteroduplex increases the T m by 2.5-6.5_C per A→D substitution. Furthermore, we show that the sequence specificity can be increased upon incorporation of a diaminopurine nucleobase in PNA.
Finally, it is demonstrated that a homopurine decamer PNA containing six diaminopurines (and four guanines) forms a strand displacement complex with a double-stranded DNA target and that this complex has sufficient stability to be analyzed by band shift assay.
MATERIAL AND METHODS
The A, C, G and T PNA monomers and N-(2-bocaminoethyl) glycine were purchased from Perseptive Biosystems. 2,6-Diaminopurine (98%) and standard chemicals were obtained from Aldrich. The phosphoramidites used for DNA synthesis were obtained from CruaChem and were incorporated into DNA oligomers according to standard protocols on a MilliGen/Biosearch 8700 DNA synthesizer. The N 2 ,N 6 -diphenoxyacetyl-2,6-diaminopurine phosphoramidite was prepared according to the literature (11) . RNA oligomers were purchased from DNA Technology and were used as received. Melting points are uncorrected. Flash chromatography was performed using Merck silica gel 60 (230-400 mesh ASTM). 1 H and 13 C NMR spectra were obtained in DMSO-d 6 at 260 nm. The column was heated to 50_C. The flow rate was 4.0 ml/min for preparative HPLC.
The PNAs were synthesized according to a published protocol (13) except for one modification: following incorporation of the first 2,6-diaminopurine monomer the usual steps of capping unreacted amines were omitted. Syntheses typically gave a crude product of >90% purity as judged by reverse phase HPLC. The PNAs were purified by reverse phase HPLC and were characterized by MALDI-TOF mass spectrometry. All PNAs showed the expected mass within 5 m.u. (0.2%).
T m measurements
Absorbance versus temperature was measured at 260 nm using a Gilford Response spectrophotometer. Heating was performed in 0.5_C steps from 5 to 90_C (∼0.7_C/min). PNA oligomers were hybridized with complementary DNA sequences in a medium salt buffer containing 100 mM NaCl, 10 mM sodium phosphate and 0.1 mM EDTA, pH 7.0. The samples were heated to 90_C for 5 min, slowly cooled to 20_C and left at 4_C for at least 30 min prior to T m measurements. The concentrations of all oligomers were determined using UV spectroscopy. The following molar extinction coefficients where used (λ = 260 nm): A, 15.4 × 10 3 ; C, 7.3 × 10 3 ; G, 11.7 × 10 3 ; T, 8.8 × 10 3 ; 2,6-diaminopurine, 7.7 × 10 3 cm -1 M -1 .
Chemical probing
The 246 bp EcoRI-PvuII fragment of a pUC19-derived plasmid containing a 5′-GATCGAGAGGAAAA target cloned into the BamHI site was used for gel shift analyses and chemical probing. The plasmid DNA fragment was labeled with 32 P ([α-32 P]dATP/ Klenow DNA polymerase fragment) at the 3′ EcoRI site. The 32 P 3′-end-labelled EcoRI-PvuII fragment was incubated with the desired amount of PNA for 1 h in 100 µl 10 mM Tris-HCl, 1 mM EDTA, pH 7.2, at room temperature (RT) and analyzed by gel electrophoresis in 5% polyacrylamide gels run in TBE (45 mM Tris-borate, 1 mM EDTA, pH 8.5) buffer (gel shift) or by chemical probing with permanganate or diethylpyrocarbonate. Probing with diethylpyrocarbonate (5 µl) was performed for 5 min at RT (with occasional vigorous mixing) and probing with KMnO 4 (1 mM final concentration) was performed for 15 s at RT. Reactions were detected as DNA strand breaks following piperidine treatment (10% piperidine at 90_C for 5 min) (cf. 14).The DNA samples were analyzed by high resolution polyacrylamide gel electrophoresis and autoradiography.
Synthesis of the 2,6-diaminopurine PNA monomer
Ethyl-2,6-diaminopurin-9-ylacetate (2) . To a suspension of finely ground 2,6-diaminopurine (1) (10.0 g, 66.6 mmol) in dry, degassed DMF (400 ml) was added portionwise NaH (2.93 g, 60% in oil, Nucleic Acids Research, 1997, Vol. 25 (15) (38.8 g 191 mmol) in DCM (85 ml). Subsequently, the title compound was precipitated by addition of ether (30 ml), isolated by filtration and washed with ether, which yielded 48.7 g (70%) of a white solid, which is stable for at least 3 months when stored dry and cold (-20_C).
Ethyl-2-amino-6-(benzyloxycarbonylamino)purin-9-ylacetate (3).
To a solution of ethyl-2,6-diaminopurin-9-ylacetate (2) (7.00 g, 29.6 mmol) in dry degassed 1,4-dioxane (250 ml) was added freshly prepared N-benzyloxycarbonyl-N′-methylimidazolium triflate (16 b 100 mM NaCl, 10 mM Na 2 HPO 4 , 0.1 mmol EDTA, pH 7.0. c DNA targets: 5′-AGT GAT CTA C-3′, 5′-GTA GAT CAC T-3′, 5′-TAG TTG TGA CGT ACA-3′. d RNA targets: 5′-AGU GAU CUA C-3′, 5′-GUA GAU CAC U-3′, 5′-UAG UUG UGA CGU ACA-3′. e PNA targets: H-AGT GAT CTA C-LysNH 2 , H-GTA GAT CAC T-LysNH 2 , H-TAG TTG TGA CGT ACA-LysNH 2 . 
2-Amino-6-(benzyloxycarbonylamino)purin-9-ylacetic acid (4).
Ethyl-2-amino-6-(benzyloxycarbonylamino)purin-9-ylacetate (3) (3.00 g, 8.1 mmol) was added to 2 M aqueous NaOH (30 ml). Dissolution occured after 1 h and the reaction was then cooled to 0_C and the product precipitated by acidifying to pH 2.5 with 2 M aqueous HCl. The solid produced was filtered, washed with water and dried yielding the title compound (4) 
Ethyl-N-(2-(t-butyloxycarbonylamino)ethyl)-N-(2-amino-6-(benzyloxycarbonylamino)purin-9-ylacetyl)glycinate (5).
A solution of 2-amino-6-(benzyloxycarbonylamino)purin-9-ylacetic acid (4) (2.00 g, 5.84 mmol), DhbtOH (1.05 g, 6.44 mmol) and DCC (1.33 g, 6.45 mmol) in dry DMF (25 ml) was stirred at room temperature for 1 h after which ethyl-N-(2-(t-butyloxycarbonylamino)ethyl)glycinate (1.50 g, 6.45 mmol) was added. The reaction was stirred for 16 h. DCU was removed by filtration and DMF removed in vacuo. Dichloromethane (50 ml) was added and the organic layer was washed with saturated NaHCO 3 (3×), saturated KHSO 4 (2×) and finally with brine. After drying (MgSO 4 ) and removal of solvent the white foam was crystallized from EtOH/H 2 O to afford the title compound (5) 
N-(2-(t-Butyloxycarbonylamino)ethyl)-N-(2-amino-6-(benzyloxycarbonylamino)purin-9-ylacetyl)glycine (6).
A solution of ethyl-N-(2-(t-butyloxycarbonylamino)ethyl)-N-(2-amino-6-(benzyloxycarbonylamino)purin-9-ylacetyl)glycinate (5) (2.0 g, 3.59 mmol) in 2 M aqueous NaOH (20 ml) and THF (15 ml) was stirred for 1 h, after which most of the THF was removed in vacuo and the aqueous layer cooled to 0_C. The product was precipitated by adjusting the pH to 4 with 4 M HCl, yielding a solid which was washed extensively with water. Drying under high vacuum gave the title compound (6) 
RESULTS AND DISCUSSION
The PNA diaminopurine monomer was synthezied as shown in Scheme 1. Briefly, 2,6-diaminopurine was alkylated at N9 with ethyl bromoacetate followed by acylation at N6 with the triflate of Rapoport's reagent. Subsequently the ethyl ester was hydrolyzed with dilute sodium hydroxide and the resulting 2-amino-6-(benzyloxycarbonylamino)purin-9-ylacetic acid (4) was coupled to ethyl-N-(2-t-butyloxycarbonylaminoethyl)glycinate utilizing DCC and DhbtOH. The diaminopurine monomer (6) was finally obtained after hydrolysis with dilute sodium hydroxide. PNA oligomers were synthesized by a modified Merrifield method as previously reported (13), except that capping was omitted subsequent to incorporation of the first diaminopurine moiety in the oligomer, as this could result in acetylation of the unprotected 2-amino group.
Four decameric (II, III, V and IX) and one pentadecameric (VII) PNA containing diaminopurine units were synthesized and the thermal stabilities of complexes between these PNAs and complementary DNA, RNA and PNA oligomers were measured (Table 1) . It is consistently observed that substituting a diaminopurine for an adenine increases the thermal stability (∆T m ) of the complexes by 4-6_C per substitution for the decamers and a little less for the pentadecamer. This increase (as compared with the decamers) appears slightly higher than that observed for the corresponding DNA oligomers (∆T m = 2.5-4_C).
Using oligomers I, II, VI and VII we also studied base recognition and discrimination by the diaminopurine (Table 2) . Not surprisingly, diaminopurine, being 'the perfect three hydrogen bond complement of thymine', recognizes thymine and, in general (apart from cytosine), discrimination (-∆T m ) against mismatches opposite the diaminopurine in a DNA, RNA or PNA complement is somewhat higher with diaminopurine-containing PNAs than with normal adenine-containing PNAs. We also observed that discrimination against mismatches proximal to the diaminopurine was slightly increased as compared with discrimination by the normal adenine-containing PNA [C 8 -X (A,C or T) in PNA VII versus VI] (∆∆T m = 1.5, 2.0 and 3.0_C for the C-A, C-C and C-T mismatches respectively).
Therefore, employment of diaminopurine in place of adenine in PNA yields oligomers that bind both more efficiently and most often with increased sequence specificity to complementary DNA, RNA or PNA oligomers.
We have recently shown that the homopurine decamer PNA VIII is able to bind to a double-stranded DNA target via strand invasion despite the fact that this PNA only forms a duplex, albeit of extraordinary high stability, with the complementary oligonucleotide (14) . However, this strand displacement complex is much less stable than the corresponding triplex formed by a homopyrimidine PNA (e.g. H-TTTTCCTCTC-LysNH 2 ) and does not, for example, allow for analysis by gel shift assay.
As shown by the chemical probing experiments presented in Figure 2 , both PNAs VIII and IX bind to the double-stranded DNA target by strand invasion: adenines within the target become sensitive to reaction with diethylpyrocarbonate, while hyperreactivity of thymines to permanganate is induced proximal to the bound PNA. It is also seen from these results that the diaminopurine PNA IX is ∼10-fold more potent than the standard PNA VIII. In fact, the strand displacement complex formed by PNA IX has sufficient stability to be analyzed by gel shift assay (Fig. 3) , although higher concentrations of the PNA result in DNA aggregation, as evidenced by the non-migrating DNA at the top of the gel (Fig. 3, lanes 8 and 9) .
Conclusion
The present results clearly demonstrate that it should be highly advantageous to substitute one or several adenines by diaminopurine in PNA oligomers for use as antigene or antisense therapeutic agents (8, (16) (17) (18) and as diagnostic or molecular biology tools (19) (20) (21) (22) (23) .
